High-risk AI systems in healthcare are tools that can greatly affect patient health, medical choices, or how healthcare is managed. Examples include AI used to find diseases early, suggest treatments, help develop drugs, or manage important tasks like scheduling patients and keeping medical records. Because mistakes or biases can cause harm, strong rules are needed.
Right now, the U.S. does not have a single national law just for AI in healthcare. But some existing laws and new rules cover parts of AI:
As AI use grows, the law must keep up to make sure AI tools are safe, clear, and fair.
Europe has new laws about high-risk AI systems, including in healthcare. The European Union’s Artificial Intelligence Act became effective on August 1, 2024. It requires:
The U.S. doesn’t have the same law yet, but health groups here can expect similar rules soon. It is important to be ready.
Health data is sensitive and must be protected. HIPAA sets national rules to guard personal health information. AI systems that use electronic health records must follow these rules to stop data leaks or hacking.
HIPAA also controls how patient data is used for research or AI work. Sometimes data must be changed so people can’t be identified, or patients must agree to its use. When AI trains on big sets of data, managing privacy becomes harder.
Healthcare groups should get legal advice to make sure AI systems handle data safely and follow HIPAA and state laws.
Many AI tools that help with diagnosis or treatment are treated as medical devices by the FDA. The FDA’s Digital Health Center guides how these AI tools get approval before use.
Health providers must keep up with FDA rules about risk levels, testing, and monitoring AI after it is in use. Some AI changes over time, which makes regulation more complex.
It is not always clear who is responsible if an AI system causes harm. Laws about malpractice don’t cover AI well yet. Europe has updated rules where software makers can be held liable for faulty AI.
The U.S. does not have special AI liability laws yet. Health providers should have clear agreements with AI vendors on who is responsible. They should also test AI carefully to lower risks.
Health providers must be able to explain AI decisions to patients and officials. Being clear about how AI works helps build trust and supports human oversight. If AI decisions cannot be explained, doctors might not accept them, and legal problems may rise if errors happen.
Safe and ethical AI in healthcare should:
Healthcare managers should choose AI vendors who offer full information about these features and support monitoring.
AI can help with routine tasks in healthcare offices and clinics. This can lessen work for staff, cut costs, and improve patient experience if done with correct rules.
Even though AI helps many processes, healthcare providers need to make sure:
Using AI in U.S. healthcare is not simple. Some challenges are:
Even with these issues, looking at Europe’s AI Act and health data rules can help guide U.S. efforts.
Many groups are working on clearer AI rules for healthcare in the U.S.:
Healthcare leaders should watch these developments to prepare. Being ready will help make AI use smoother and safer for patients and staff.
In the United States, adding AI to healthcare means working with changing laws that focus on safety, clarity, and responsibility. Although there is no single AI law like Europe’s, HIPAA and FDA rules, along with new standards, guide safe AI use.
AI can improve many tasks in hospitals and clinics, such as phone automation, scheduling, documentation, and managing resources. Medical leaders need to make sure AI respects privacy, allows human control, and has clear rules for responsibility.
Learning from other countries and following legal and ethical rules will help healthcare groups use AI well. This careful way is needed for AI to become a trusted part of healthcare in the U.S.
AI improves healthcare by enhancing resource allocation, reducing costs, automating administrative tasks, improving diagnostic accuracy, enabling personalized treatments, and accelerating drug development, leading to more effective, accessible, and economically sustainable care.
AI automates and streamlines medical scribing by accurately transcribing physician-patient interactions, reducing documentation time, minimizing errors, and allowing healthcare providers to focus more on patient care and clinical decision-making.
Challenges include securing high-quality health data, legal and regulatory barriers, technical integration with clinical workflows, ensuring safety and trustworthiness, sustainable financing, overcoming organizational resistance, and managing ethical and social concerns.
The AI Act establishes requirements for high-risk AI systems in medicine, such as risk mitigation, data quality, transparency, and human oversight, aiming to ensure safe, trustworthy, and responsible AI development and deployment across the EU.
EHDS enables secure secondary use of electronic health data for research and AI algorithm training, fostering innovation while ensuring data protection, fairness, patient control, and equitable AI applications in healthcare across the EU.
The Directive classifies software including AI as a product, applying no-fault liability on manufacturers and ensuring victims can claim compensation for harm caused by defective AI products, enhancing patient safety and legal clarity.
Examples include early detection of sepsis in ICU using predictive algorithms, AI-powered breast cancer detection in mammography surpassing human accuracy, and AI optimizing patient scheduling and workflow automation.
Initiatives like AICare@EU focus on overcoming barriers to AI deployment, alongside funding calls (EU4Health), the SHAIPED project for AI model validation using EHDS data, and international cooperation with WHO, OECD, G7, and G20 for policy alignment.
AI accelerates drug discovery by identifying targets, optimizes drug design and dosing, assists clinical trials through patient stratification and simulations, enhances manufacturing quality control, and streamlines regulatory submissions and safety monitoring.
Trust is essential for acceptance and adoption of AI; it is fostered through transparent AI systems, clear regulations (AI Act), data protection measures (GDPR, EHDS), robust safety testing, human oversight, and effective legal frameworks protecting patients and providers.
Simbo is using AI agents to automate all phone related workflows. Connect now to know more.
Schedule AI Agents Demo Now© Since 2019, Simbo AI.
